Moderna announced it is bringing drug product manufacturing to its Norwood, Massachusetts technology center, completing end-to-end US production for its mRNA medicines. Construction has begun, with the facility set to be finished in the first half of 2027. CEO Stephane Bancel said the move fully onshores Moderna's manufacturing loop under one roof.